Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
8m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
8m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
32m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
32m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
32m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

About

Teva Pharmaceutical Industries Ltd (TA:TEVA) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 15 2026
Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners
Apr 14 2026
Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics
Mar 30 2026
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
Mar 19 2026
Teva Releases Q1 2026 Aide Memoire
Mar 19 2026
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026

Financials

Revenue
ILA17.26 B
Market Cap
ILA1.09 B
P/E Ratio
24.55
EPS
3.80

Community Chat

Ask AI

6ix6ixAIEvents